SCHEMBL25898629

SCHEMBL25898629

CCC(=O)[C@H](Cc1ccccc1)C(C)C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 1/20 0.49
SLC1A2 P43004 1/20 0.49
SLC1A1 P43005 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
TRPA1 O75762 2/20 0.48
CYP1A2 P05177 1/20 0.47
ACE P12821 2/20 0.46
SLC15A1 P46059 1/20 0.46
TAAR1 Q96RJ0 3/20 0.46
SIGMAR1 Q99720 2/20 0.46
SLC18A2 Q05940 1/20 0.46
ALPI P09923 1/20 0.44
PKM P14618 1/20 0.44
PTGS1 P23219 1/20 0.44
XIAP P98170 1/20 0.44
SLC7A5 Q01650 1/20 0.44
MAOA P21397 1/20 0.44
SLC6A2 P23975 1/20 0.44
SLC6A4 P31645 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22431701 1.00 SLC1A3 (0.49) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL17429778 0.85 TSHR (0.49) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL19287592 0.84 SLC1A3 (0.47) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL5511480 0.82 SLC1A3 (0.63) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL883357 0.82 SLC1A3 (0.63) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL19647227 0.81 ALPI (0.52) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL31112245 0.81 HPGD (0.54) NPC1RAB9ATRPA1CYP1A2SLC15A1
SCHEMBL13545160 0.81 HPGD (0.54) NPC1RAB9ATRPA1CYP1A2SLC15A1
SCHEMBL12768183 0.81 ALPI (0.52) SLC1A3SLC1A2SLC1A1NPC1RAB9A
SCHEMBL3463488 0.80 SLC1A1 (0.61) SLC1A3SLC1A2SLC1A1CYP1A2ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230233690-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS UNIV MICHIGAN REGENTS (US) 2023-07-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230233690-A1 ANDROGEN RECEPTOR PROTEIN DEGRADERS AR, SHBG, CYP19A1 SLC1A3 4040/4885SLC1A2 4279/4885SLC1A1 3712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.